Having trouble accessing articles? Reset your cache.

Anacor, Pfizer deal

Pfizer will acquire Anacor for $99.25 per share in cash, or about $5.2 billion net of

Read the full 164 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE